Infectious Complications in Biologic and Targeted Therapies is popular PDF and ePub book, written by Carlos Cervera in 2022-11-18, it is a fantastic choice for those who relish reading online the Medical genre. Let's immerse ourselves in this engaging Medical book by exploring the summary and details provided below. Remember, Infectious Complications in Biologic and Targeted Therapies can be Read Online from any device for your convenience.
Infectious Complications in Biologic and Targeted Therapies Book PDF Summary
This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.
Detail Book of Infectious Complications in Biologic and Targeted Therapies PDF
- Author : Carlos Cervera
- Release : 18 November 2022
- Publisher : Springer Nature
- ISBN : 9783031113635
- Genre : Medical
- Total Page : 466 pages
- Language : English
- PDF File Size : 17,9 Mb
If you're still pondering over how to secure a PDF or EPUB version of the book Infectious Complications in Biologic and Targeted Therapies by Carlos Cervera, don't worry! All you have to do is click the 'Get Book' buttons below to kick off your Download or Read Online journey. Just a friendly reminder: we don't upload or host the files ourselves.